Načítá se...
Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical neuroleptics, has been described so far. In the past few years, there has been increased use of atypical antipsychotic drugs. Cases of NMS related to atypical neuroleptics, such as olanzapine, are less common in spi...
Uloženo v:
| Vydáno v: | J Family Med Prim Care |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5629885/ https://ncbi.nlm.nih.gov/pubmed/29026773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2249-4863.214969 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|